http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101774633-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 |
| filingDate | 2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101774633-B1 |
| titleOfInvention | A pharmaceutical composition for inhibiting cancer metastasis using regulation of BIGH3 |
| abstract | The present invention relates to a pharmaceutical composition for inhibiting cancer metastasis through modulation of BIGH3 protein. The pharmaceutical composition of the present invention has a great effect on the inhibition of cancer metastasis to primary organs, and thus it is expected to be greatly utilized in cancer treatment field. |
| priorityDate | 2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 381.